The Indian pharma and health sectors’ growth hinges on value-driven research, global supply chain integration, and equitable access.
In brief
- The Indian pharmaceutical industry aspires to reach the milestones of US$130 billion by 2030 and US$450 billion by 2047 as part of the India@100 vision.
- This upward trajectory will be propelled by the industry’s commitment to innovation, integration with the global pharmaceutical landscape, and access to integrated healthcare.
- Nurturing of talent, development of essential skillset, and expansion of capacity will be indispensable elements underpinning this ambitious growth.
